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METHOXSALEN IN ULTRAVIOLET CARCINOGENESIS IN THE MOUSE
A. CLARK GRIFFIN, Ph.D.*
The involvement of ultraviolet light in the
induction of skin cancer has been established
in both man and animals. Roffo (1) in 1934
demonstrated that prolonged exposure of albino
rats to sunlight would result in a high incidence
of tumors in the exposed areas. Many other
investigators have shown that ultraviolet irradia-
tion will result in a high incidence of skin tumors
in animals, Findlay (2), Blum (3, 4), Ruseh and
associates (5), Kelner and Taft (6), Griffin and
coworkers (7—10). The eareinogenieity of ultra-
violet light has also been established by Rogers
(11, 12) by the rapid in vitro induction of pul-
monary adenomas in fetal mouse lung exposed
to short wave length ultraviolet. The evidence is
also overwhelming that a large percentage of
skin cancer in man is caused by prolonged
exposure to sunlight. Macdonald (13) has re-
ported that skin cancer is more prevalent in
areas of high sun intensity. The tumors appear
on the exposed surfaces of the body and fair
complexioned individuals are more susceptible
than dark skinned peoples or than individuals
who undergo normal pigmentation and tanning.
Considerable effort has been expended in
many different laboratories in order to obtain
a better understanding of ultraviolet careino-
genesis. Some of the factors or mechanisms
involved will be included in the discussion of this
presentation. Certainly, the presence of specific
chemical drugs or metabolites may alter the
response of the skin to exposure to light of
ultraviolet or other wave bands (3). Of all
known substances the psoralens are perhaps
the most active in this respect. The application
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of these drugs in the treatment of vitiligo or in
the enhancement o pigmentation has been most
adequately covered in this symposium. It was
the observations of Fitzpatrick and associates
(14) of enhanced pigmentation resulting from
the pre-administration of methoxsalen (8-MP
or 8-MOP) and subsequent ultraviolet or sun-
light exposure that prompted our own interest
as to the effect these drugs may have in skin
cancer induction.
EXPERIMENTAL METIIOD5 AND RESULTS
The procedure for the induction of skin
tumors in all of these studies was that described
by Rusch and associates (5) with some modifi-
cations by our group (7—9). It has been estab-
lished that approximately 100 daily exposures of
10—20 minutes to the total spectrum of the high
voltage mercury are lamps (G.E. Uviare-UA-3)
results in the appearance of ear tumors in a
high percentage of albino mice. Approximately
10 percent of these animals will also develop
tumors of the eye. From these observations it
may be calculated that 14—16 x l0 ergs per sq.
cm. of total ultraviolet energy is required for
tumor production. Ruseh et al. (5) have reported
that 6—8 x 10 ergs per sq. em. of "mid-ultra-
violet" radiation was adequate for ear tumor
formation in Swiss mice.
Methoxsalen was given either orally or intra-
peritoneally to determine what effect these com-
pounds may have upon ultraviolet cancer induc-
tion in albino mice exposed to the total spectrum
of uviare lamps (8). The groups were as follows
(40 female Swiss mice per group):
Group lA—Controls, U.V. only.
Group 1B—Methoxsalen, 0.4 mg/mouse/day,
injected intraperitoneally one hour before U.V.
exposure.
Group 1C—Methoxsalen, 0.5 gm/kg in
ground Purina Laboratory Chow.
After approximately 100 days the psoralen
and also the ultraviolet irradiation were discon-
tinued and the animals were observed periodically
for erythemal effects and ear tumor formation.
The findings are shown in Figure 1. Intraperi-
toneal administration of methoxsalen resulted
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Fia. 1. Effect of 8-methoxypsoralen on the inci-
dence of ear tumors in mice exposed to ultraviolet
light. Series I: U.V., 15 minutes/day. Group 1A:
Controls, U.V. only. Group 1B: S-MP, 0.4 mg/day,
injected intraperitoneally. Group 1C: S-MP in
diet, 0.5 mg/kg diet.
in a severe erythemal response to the ultraviolet.
This was evident within a few weeks after the
study was initiated. In addition to the burning
with subsequent scar tissue formation about
the ears, eyes and face, these animals all de-
veloped ear tumors. The erythemal and carcino-
genic response observed in this group was in-
creased considerably over that observed in the
non-drug controls in this series. In contrast
the more gradual incorporation of the psoralen
by the oral administration produccd a different
response to the ultraviolet exposure. These
animals had even less erythcmal damage than
the controls and a lower tumor incidence than
either of the other two groups.
From the above findings it is apparent that
the mode of administration and the dosage of
mcthoxsalen had considerable influence upon
the animal response to ultraviolet irradiation.
When the same amount of the psoralen (0.4 mg)
was injected I.P. 24 hours instead of 1 hour
before DV. exposure the marked erythcmal and
carcinogenic response was considerably lessened.
This would indicate that the drug was metabo-
lized and excreted during this period. We have
no immediate explanation for either the enhance-
ment or the protection afforded by the drug in
this particular study. Attempts to achieve a
greater protection from ultraviolet exposure by
dietary administration of methoxsalen have not
been successful. Under the conditions established
in our laboratory, the oral administration of
methoxsalen (up to levels of 1.0 gm/kg of diet)
has either protected or has had no effect on the
_1R final tumor incidence when compared to the
non-psoralen controls of the same series.
Kelner and Taft (6) and Griffin et at. (9) have
demonstrated that the lower portion of the
ultraviolet spectrum will initiate carcinogencsis
in albino mice. Accordingly, we wished to ascer-
tain if methoxsalen had any effect upon cancer
induction resulting from prolonged exposure
to the germicidal type lamps with a principle
emission at 2537 A. A study was carried out
similar to that just described above, employing
this lower wave length source of ultraviolet
light (9, 10). The results of this investigation
are shown in Table 1. It is evident that this
exposure will initiate carcinogenesis in the ears
and eyes of albino mice. However, this wave
length is considerably less effective than the
longer ultraviolet spectrum. Methoxsalen, given
intraperitoneally, did not accentuate carcino-
genesis following exposure to the 2537 A lamps.
Approximately 10-20 per cent of these mice
developed car tumors which was very close to that
observed in the control groups. The psoralen
dietary group in this series exhibited a very mild
erythemal response and no tumors appeared.
In this respect the findings are similar to those
obtained in the earlier study involving the
entire ultraviolet spectrum.
The next phase of this investigation was
directed to the effects of mcthoxsalcn following
exposure of albino mice to the longer portion
of the ultraviolet spectrum. The same experi-
mental approach was followed as described in
the preceeding studies. Woods' type ultraviolet
lamps (Blak-Ray Model XX15 Long Wave
Ultraviolet) were used for the source of radiatiOn.
From past observations we have found that mice
could withstand prolonged exposure to this form
of light without any erythemal effects or ap-
pearance of tumors. Administration of methox-
salcn, especially by the intraperitoneal route
and subsequently followed by the long ultra-
violet irradiation, resulted in the most severe
erythcmal response ever seen in our laboratories,
Table 2 (9, 10). These findings clearly point out
the photosensitizing capacity of the psoralen
compounds in animals exposed to long wave
length ultraviolet. In group 7, control mice were
exposed to a total of 13.4 x 10 ergs per sq. cm. of
the long wave ultraviolet with no visible signs
of erythemal damage and no tumors were cvi-
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TABLE 1 (Ref. 9)
dent. In contrast (group 11, Table 2), wherein
methoxsalen was injected intraperitoneally be-
fore irradiation, a total exposure of less than five
per cent of the above (4.3 X lO ergs per sq.
cm.) resulted in severe burning of the ears,
eyes and face, corneal opacity, cataracts, and
ear tumors in all animals. Possible explanations
for these marked effects will be considered in the
discussion section.
A small percentage of the total emission from
ordinary fluorescent light is in the ultraviolet
range (15). Kline and Rusch (16), however,
were unable to induce tumors in albino mice
following prolonged exposure to fluorescent
light. In view of our findings with psoralen
activation of long wave length ultraviolet, we
have irradiated control mice, mice given methox-
salen in the diet (0.5 gm per Kg.) and mice
injected with the psoraleri intraperitoneally
(0.4 mg per mouse), for long periods of time with
ordinary fluorescent lighting. In two separate
studies we have demonstrated an erythemal
response and actual ear tumor formation in the
psoralen-injected groups. No changes were seen
in the other two groups. It would appear that
the emission from the fluorescent lamps is
activated by certain concentrations of psoralen
or psoralen metabolites in the skin resulting in a
considerable erythema response.
An understanding of the metabolism of the
psoralen compounds is essential in order to
explain or predict the photodynamic properties
of these compounds. Attempts to obtain C'
labeled psoralens have not been successful;
however, tritium labeled methoxsalen has been
made available*. This preparation has an activity
of approximately 75,000 counts per mg. There
are inherent difficulties in making accurate
counts on tritium labeled samples with conven-
* Through the courtesy of Dr. F. S. Rowland,
Department of Chemistry, University of Kansas,
Lawrence, Kansas.
Methoxsalen adminis-
tration
Eryihemal and Carcinogenic Response Associated With Administration of Methoxsalen and Subsequent
Exposure to Ultraviolet Light (2537 A)
Treatment Results
Group
Number
1
Ultraviolet irradiation Gross observations after10 months of irradiation
I.P. injection of
0.4mg 1 hr. prior
to U.V. exposure
Gross appearance one month
after discontinuance of
irradiation
Moderate ery-
themal damage
of ears and eyes
20 minutes daily
first 3 months,
further in-
creased to 60
mm. exposure
for next 7 mo.
(total 8.3 X 108
ergs/cm2)
Final tumor
incidence
percent
10—20%Some evidence of
sear tissue on ears
from previous ery-
themal damage.
Mild cornea! opac-
ities and possible
cataract formation
in approximately
20% of surviving
animals. Tumors
present on ears.
Mixed in diet, 0.5
gm per kg. of
chow
No medication
2
3
4
Slight erythemal Normal 0
damage of ears
and eyes
Mild erythemal
damage of ears
and eyes
I.P. injection of Controls, no ir-
0.4 mg daily
Slight indication of
erythemal damage
in ears. Some ani-
mals had mild cor-
nea! opacity.
radiation
Normal
20%
0Normal
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Erythemal and Carcinogenic Response Associated with Administration of Methoxsalen and Subsequent
Exposure to Long-Wave Length Ultraviolet Light
Group
Number
Treatment Results
Methoxsalen .Ultraviolet .Gross observations Tumor incidence
5
6
7
0.4 mg I.P. one hour
before UV expos-
ure
0.5 g/Kg diet
Controls
2 hours daily for 3
months (total 13.4 X
100 ergs/cm2)
Same as above
Same as above
Severe erythemal response.
All animals dead within
14 days.
Ears and tails severely
burned. Eyes opaque
with cataract formation.
Normal appearance
—
35%
0
8
9
10
0.4 mg I.P. one hour
before UV expos-
ure
0.5 g/Kg diet
Controls
30 mm. daily for 3
months (2.6 X 10
ergs/cm2)
Same as above
Same as above
Face, head and tails se-
verely burned with sub-
sequent sluffing of tissue
and scar tissue forma-
tion. Eyes opaque, scari-
fied with cataract forma-
tion.
Ears and eyes burned, but
to lesser extent than
noted in group 9 above.
Normal appearance
5Q%* or over
25%
0
11
12
13
0.4mgI.P. 1 hour be-
fore UV exposure
0.5 g/Kg diet
Controls
10mm. dailyfor6 week
period. (4.3 X 108
erg/cm2)
Same as above
Same as above
Tumors in both ears, eyes
burned, corneal opacity
and cataracts.
Moderate erythemal dam-
mage to eyes and ears.
Normal appearance
100%*
20%
0
* In these groups it was difficult to arrive at an accurate tumor incidence. The scar tissue as well as
other remaining erythemal damage was still considerable. From both gross and microscopic examina-
tion the final tumor incidence in these groups was high.
tional window-less gas flow counters. However,
in our preliminary observations it has been
observed that measurable amounts of intra-
peritoneally injected methoxsalen (or metabolites
thereof) do appear in the skin of albino mice. The
brain was the only other tissue wherein tritium
activity could be detected. These results, while
obviously of a preliminary nature, would in-
dicate a concentration of the drug or its metabo-
lites in the skin.
DISCUSSION
Throughout this study we have been concerned
with the extensive changes seen in the eyes of the
animals given psoralen and exposed to ultraviolet
light. In past investigations we have noted that
approximately ten per cent of ultraviolet light-
irradiated mice have developed eye tumors.
Kelner and Taft (6) made somewhat similar
observations following exposure to the 2537 A
lamps. Following the intraperitoneal administra-
tion of methoxsalen and subsequent exposure to
the total spectrum of the mercury arc very
obvious and extensive lesions have appeared.
These include corneal opacities, scarification,
cataract formation and a high incidence of tumor
formation. Even more pronounced effects have
been obtained with the combination of the
psoralen and exposure to the long wave length
ultraviolet source. It should also be mentioned
that the intraperitoneal administration of
methoxsalen with subsequent exposure to fluores-
cent light has resulted in cataract formation
in albino mice. No eye tumors have appeared in
this group. Rats are also susceptible to these
same alterations in the eyes when given the
METHOXSALEN IN ULTRAVIOLET CARCINOGENESIS 371
psoralen and ultraviolet irradiation. Since our
initial efforts were more concerned with skin
tumorigenesis, little direct attention was paid
to the eye changes. Currently, we are making
detailed gross and microscopic studies of these
changes in the eye.
Little is known concerning the actual mech-
anism in malignant transformation of tissues
exposed to ultraviolet light. In all instances there
is extensive destruction of tissues and cellular
proliferation subsequently occurs. During this
process of new cell formation or during mitosis
the ultraviolet radiation probably results in
alterations in the nucleoproteins of the chromo-
somes. The mutagenicity of ultraviolet light is
well established. Recently, Haas and Doudney
(17) have reported that E. coil cultures syn-
chronized in growth and division exhibit an
increased mutation frequency when exposed to
short term incubation in a medium supplemented
with purines and pyrimidines just prior to ultra-
violet irradiation. They found that this in-
crease in mutation frequency was attained during
periods of maximum nucleic acid synthesis.
Presence of the psoralen compounds may
result in biosynthesis of altered nucleoproteins
when cells are exposed to ultraviolet radiation.
Altenburg (18) has reported that application
of methoxsalen to the polar caps of Drosophila
resulted in a greater number of mutations when
the organisms were exposed to ultraviolet light.
Other than the points already mentioned, we
cannot explain the effects of the psoralen upon
ultraviolet carcinogenesis. A better under-
standing is required of the metabolism or distri-
bution of these compounds within the body. In
mammals with the capacity to pigment we would
like to believe that methoxsalen would promote
pigmentation and thereby protect exposed areas
from subsequent ultraviolet irradiation. It is
even more difficult to explain the protective
effect observed when dietary psoralen was given
to the irradiated albino mice. With the intra-
peritoneal administration of the psoralen we may
assume that relatively large quantities of the
drug or its metabolites are concentrated in the
skin. During ultraviolet exposure the drug ex-
hibits the property of fluorescence giving off
ultraviolet light of other wave lengths. The light
emitted is optimal for the initiation of erythema
and the other untoward effects that have been
observed. The psoralens do possess fluorescing
properties.
The studies involving the combination of
psoralen and long wave length ultraviolet light
would further indicate that fluorescence must
play a major role in the mechanism of action of
these drugs. It is possible that the psoralens
only initiate pigmentation and other erythemal
effects by exposure to the longer portion of the
ultraviolet spectrum. There is need for further
studies with controlled wave band irradiation.
It should also be pointed out that the visible
spectrum may exert considerable influence upon
the induction of cancer by ultraviolet irradiation.
Finally, it must be recognized that the ana-
tomical and chemical composition of the skin
may vary considerably from species to species
or within species. The careful studies of Baumann
and coworkers (19—22) with respect to the
metabolism and composition of the skin sterols
point out these differences and also give some
indication of the changes which may occur during
ultraviolet or chemical careinogenesis. From the
many reports presented during this symposium
it is apparent that some progress has been made
regarding the action of the psoralens and other
photosensitizing compounds and also in man's
reaction or response to his light environment.
REFERENCES
1. ROFFO, A. H.: Cancer et Soleil. Carcinomes et
sareomes provoqués par l'aetion du soleil io
toto. Bull. Assoe. Franc. étude Cancer, 23:
590, 1933.
2. FINOLAY, G. M.: Ultraviolet light and skin
cancer. Laneet 2: 1070, 1928.
3. BLUR, H. F.: Photodynamie Action and Dis-
eases Caused by Light. New York: Rhein-
hold Publ. Co., 1941.
4. Bviu, H. F.: Ultraviolet Radiation and Can-
cer. In: A. Hollaender (ed.), Radiation
Biology, Vol. 2. New York: McGraw-Hill,
1955.
5. Rusen, H. P., KLINE, B. E. AND BAUMANN,
C. A.: Careinogenesis by ultraviolet rays
with reference to wavelength and energy.
Arch. Path., 31: 135, 1941.
6. KRLNER, A. AND TAFT, E. B.: The influence ofphotoreaetivating light on the type and
frequency of tumors induced by ultraviolet
radiation. Cancer Research, 16: 860, 1956.
7. GRIFFIN,A.C.,D0LMAN,V.S.,BöHLIR,E.B.,
BOUvART, P. AND TATUM, E. D.: The effect
of visible light on the earcinogenieity of
ultraviolet light. Cancer Research, 15:
523, 1955.
S. O'NRAL, M. A. AND GRIFFIN, A. C.: The effect
of oxypsoralen upon ultraviolet eareino-
genesis in albino mice. Cancer Research, 17:
911, 1957.
9. GRIFFIN, A. C., HAKIM, R. E. ANn Kxox, J.:
The wave length effect upon erythemal and
carcinogenic response in psoralen treated
mice. J. Invest. Dermat. In press.
372 THE JOUHNAL OF INVESTIGATIVE DEEMATOLOGY
10. GRIFFIN, A. C., O'NEAL, M. A. AND HAKIM,
R.: Factors affecting the induction of cancer
by ultraviolet light. Texas Reports Biol.
and Med. In press,
11. ROGERS, S.: The in euro initiation of pulmo-
nary adenomas in fetal mouse lung by a
single exposure to ultraviolet irradiation of
wavelength 2,537 A., J. Natl. Cancer Insti-
tute 15: 1001, 1955.
12. RoGERs, S.: Studies of the mechanisms of
ultraviolet eareinogenesis. 12th Annual
Symposium on Fundamental Cancer Re-
search, March 6, 7, 8, 1958. The University
of Texas M. D. Anderson Hospital and
Tumor Institute.
13. MACDONALD, E. J.: The present incidence and
survival picture in cancer and the promise
of improved prognosis. Bull. Am. Coll.
Surgeons, pp. 1—18, June, 1948.
14. FITZPATRICK, T. B., HoPKINs, C. E., BLICKEN-
STAFF, D. D. AND SWIFT, S.: Augmented
pigmentation and other responses of normal
human skin to solar pigmentation following
oral administration of 8-methoxypsoralen.
J. Invest. Dermat., 25: 187, 1955.
15. Lucxnsu, M. AND TAYLOR, A. H.: Radiant
energy from fluorescent lamps. Ilium. Eng.,
40: 77, 1945.
16. KLINE, B. E. AND RuscE, H. P.: Effects of
prolonged irradiation of mice with fluores-
cent light. Proc. Exper. Biol. & Med., 60:
245, 1945.
17. HAAS, F. L. AND DOUDNEY, C. 0.: A relation
of nucleic acid synthesis to radiation-in-
duced mutation frequency in bacteria.
Academy Sciences, 43: 871, 1957.
18. ALTENBtTRG, E.: Studies on the Enhancement
of Mutation Rate by Carcinogens. Reports,
10th Annual Symposium on Fundamental
Cancer Research, The University of Texas
M. D. Anderson Hospital and Tumor Insti-
tute, March, 1956.
19. WELLS, W. W. AND BAUMANN, C. A.: Skin
sterols. V. Effect of ultraviolet light on the
sterols of rat skin. Arch. Biochem. and
Biophys., 53: 471, 1954.
20. BROOKS, S. C., JR., LALICH, J. J. AND BAD-
MANN, C. A.: Skin sterols. XI. A direct
demonstration of fast-acting sterols in the
sebaceous glands. Am. J. Path., 32: 1205,
1956.
21. BROOKS, S. C., LALICH, J. J. AND BAUMANN,C. A.: Skin sterols. XII. Contrasting effects
of certain mercaptans, amines, and related
compounds on sterols and sebaceous glands.
Cancer Research, 17: 148, 1957.
22. BROOKS, S. C. AND BAUMANN, C. A.: Skin
sterols. XIII. Incorporation of acetate into
various sterols by skin slices. J. Biol. Chem.,
229: 329, 1957.
